Vladimir A. Aladinskiy

9 Institutskiy Lane, Dolgoprudny City
Moscow, MOW 141700, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Molecular LEGION: incalculably large coverage of chemical space around the NLRP3 target.

Molecular LEGION: incalculably large coverage of chemical space around the NLRP3 target.

Journal: Scientific data

Published: September 15, 2025

Traf2- and Nck-interacting kinase inhibitors: a patent review (2008-2024).

Traf2- and Nck-interacting kinase inhibitors: a patent review (2008-2024).

Journal: Expert opinion on therapeutic patents

Published: August 18, 2025

Identification of Novel pan-KRAS Inhibitors via Structure-Based Drug Design, Scaffold Hopping, and Biological Evaluation.

Identification of Novel pan-KRAS Inhibitors via Structure-Based Drug Design, Scaffold Hopping, and Biological Evaluation.

Journal: ACS medicinal chemistry letters

Published: February 13, 2025

Discovery of Bis-imidazolecarboxamide Derivatives as Novel, Potent, and Selective TNIK Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis.

Discovery of Bis-imidazolecarboxamide Derivatives as Novel, Potent, and Selective TNIK Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis.

Journal: Journal of medicinal chemistry

Published: October 18, 2024

A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models.

A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models.

Journal: Nature biotechnology

Published: June 26, 2023

Chemistry42: An AI-Driven Platform for Molecular Design and Optimization.

Chemistry42: An AI-Driven Platform for Molecular Design and Optimization.

Journal: Journal of chemical information and modeling

Published: February 02, 2023

AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor.

AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor.

Journal: Chemical science

Published: October 14, 2022

Non-rigid Diarylmethyl Analogs of Baloxavir as Cap-Dependent Endonuclease Inhibitors of Influenza Viruses.

Non-rigid Diarylmethyl Analogs of Baloxavir as Cap-Dependent Endonuclease Inhibitors of Influenza Viruses.

Journal: Journal of medicinal chemistry

Published: August 14, 2020

Synthesis, inhibitory activity and oral dosing formulation of AV5124, the structural analogue of influenza virus endonuclease inhibitor baloxavir.

Synthesis, inhibitory activity and oral dosing formulation of AV5124, the structural analogue of influenza virus endonuclease inhibitor baloxavir.

Journal: The Journal of antimicrobial chemotherapy

Published: July 17, 2020

Molecular Sets (MOSES): A Benchmarking Platform for Molecular Generation Models.

Molecular Sets (MOSES): A Benchmarking Platform for Molecular Generation Models.

Journal: Frontiers in pharmacology

Published: May 25, 2020

Synthesis, biological evaluation and in silico modeling of novel pan-genotypic NS5A inhibitors.

Synthesis, biological evaluation and in silico modeling of novel pan-genotypic NS5A inhibitors.

Journal: Bioorganic & medicinal chemistry

Published: February 11, 2020

Synthesis, biological evaluation and in silico modeling of novel integrase strand transfer inhibitors (INSTIs).

Synthesis, biological evaluation and in silico modeling of novel integrase strand transfer inhibitors (INSTIs).

Journal: European journal of medicinal chemistry

Published: October 07, 2019

Showing 1-12 of 31

Last Updated: 09/26/2026